Novartis Settles Famvir Patent Dispute

Law360, New York (August 23, 2011, 4:24 PM EDT) -- Novartis Pharmaceuticals Corp. agreed on Monday to settle a suit in Washington federal court accusing Indian generics maker Macleods Pharmaceuticals Ltd. of infringing a Novartis patent in its quest to produce a generic version of the herpes treatment Famvir.

U.S. District Judge James E. Boasberg signed an order dismissing the case without prejudice Monday after both parties filed a stipulation saying they'd come to an agreement.

Representatives for the parties could not be immediately reached for comment Tuesday, and further details about the settlement were not...
To view the full article, register now.